Vol.

No.

March 11, 2022Mar 11, 2022

DOWNLOAD THE PDF

To help Ukraine’s cancer patients, a coalition of U.S., European cancer groups aims to provide a coordinated response

Cover Story

Free

To help Ukraine’s cancer patients, a coalition of U.S., European cancer groups aims to provide a coordinated response

By Matthew Bin Han Ong

All scheduled cancer care across Ukraine has been stopped as more than 60 hospitals have been badly damaged in the course of Russia’s invasion, Ukrainian oncologists say.

Free

Ukraine crisis: Resources for health professionals

Free

ACS, ASCO, and Jefferson Health open care hotline for Ukraine’s cancer patients

By Alice Tracey

Free Guest Editorial

Collaborating to support continuing cancer care for Ukrainians

By Julie R. Gralow

Free Guest Editorial

The risk of a nuclear catastrophe in Ukraine is growing

By Robert Peter Gale

Free Guest Editorial

Latino cancer health equity, Cancer Moonshot converge in San Antonio

By Ruben A. Mesa, Amelie G. Ramirez, Patricia I. Moreno, Barbara Segarra-Vazquez and Laura Fejerman

Free In the Archives

Women’s History Month: Breaking ground in the 1940s

In Brief

Congress passes spending bill, ending current CR and giving $1 billion to ARPA-H

Mark Foundation awards $12M in Endeavor Awards to multidisciplinary cancer research teams

$10M gift to support research at renamed Ellen and Ronald Caplan Cancer Center of The Wistar Institute

ACS grants $4.08M to Illinois Cancer Health Equity Research Center

Prevent Cancer Foundation awards seven $100,000 research grants

Debbie Weir named CEO of Cancer Support Community

Funding Opportunities

Thermo Fisher opens submissions for grant supporting research in cancer molecular profiling

NYU course on preapproval access offers scholarship for patients, patient advocates

Clinical Roundup

Ribociclib added to endocrine therapy extends survival in postmenopausal metastatic breast cancer patients

UTHealth study shows increases in HPV-related cancers in areas with high smoking rates

Vanderbilt study: World Trade Center responders at higher risk for blood cancer-associated mutations

NYU study: Alzheimer’s protein protects metastasized melanoma cells in the brain

City of Hope’s investigational COVID-19 vaccine generates robust immune response

Boston Cell Standards establishes Consortium for Analytic Standardization in Immunohistochemistry

CSC, CCA partner to expand Cancer Experience Registry

Karmanos Cancer Institute, Lifeguard Health Networks to pilot virtual care platform

Drugs & Targets

FDA approves Opdivo and platinum-doublet chemotherapy for early-stage NSCLC

FDA grants priority review to Tibsovo in combination with azacitidine in previously untreated IDH1-mutated AML

FDA clinical trial guidances touch on Biden administration’s goals for advancing development of cancer treatments

Six months after court-ordered deadline, FDA hasn’t ruled on major e-cigarette manufacturers’ product applications, advocates say

NCI Trials

NCI Trials for March 2022

The National Cancer Institute approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 52 | Issue 35 - September 25, 2026

To help Ukraine’s cancer patients, a coalition of U.S., European cancer groups aims to provide a coordinated response

Ukraine crisis: Resources for health professionals

ACS, ASCO, and Jefferson Health open care hotline for Ukraine’s cancer patients

Collaborating to support continuing cancer care for Ukrainians

The risk of a nuclear catastrophe in Ukraine is growing

Latino cancer health equity, Cancer Moonshot converge in San Antonio

Women’s History Month: Breaking ground in the 1940s

In Brief

Congress passes spending bill, ending current CR and giving $1 billion to ARPA-H

Mark Foundation awards $12M in Endeavor Awards to multidisciplinary cancer research teams

$10M gift to support research at renamed Ellen and Ronald Caplan Cancer Center of The Wistar Institute

ACS grants $4.08M to Illinois Cancer Health Equity Research Center

Prevent Cancer Foundation awards seven $100,000 research grants

Debbie Weir named CEO of Cancer Support Community

Funding Opportunities

Thermo Fisher opens submissions for grant supporting research in cancer molecular profiling

NYU course on preapproval access offers scholarship for patients, patient advocates

Clinical Roundup

Ribociclib added to endocrine therapy extends survival in postmenopausal metastatic breast cancer patients

UTHealth study shows increases in HPV-related cancers in areas with high smoking rates

Vanderbilt study: World Trade Center responders at higher risk for blood cancer-associated mutations

NYU study: Alzheimer’s protein protects metastasized melanoma cells in the brain

City of Hope’s investigational COVID-19 vaccine generates robust immune response

Boston Cell Standards establishes Consortium for Analytic Standardization in Immunohistochemistry

CSC, CCA partner to expand Cancer Experience Registry

Karmanos Cancer Institute, Lifeguard Health Networks to pilot virtual care platform

Drugs & Targets

FDA approves Opdivo and platinum-doublet chemotherapy for early-stage NSCLC

FDA grants priority review to Tibsovo in combination with azacitidine in previously untreated IDH1-mutated AML

FDA clinical trial guidances touch on Biden administration’s goals for advancing development of cancer treatments

Six months after court-ordered deadline, FDA hasn’t ruled on major e-cigarette manufacturers’ product applications, advocates say

NCI Trials

NCI Trials for March 2022

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login